GS-441524 CAS 1191237-69-0
Antiviral Nucleoside Analog (Remdesivir Metabolite)
GS-441524 (CAS 1191237-69-0) is the active nucleoside metabolite of remdesivir. Intracellularly phosphorylated to its triphosphate, it terminates viral RNA chain elongation by the viral RNA-dependent RNA polymerase (RdRp), blocking replication of coronaviruses including feline infectious peritonitis virus (FIPV) and SARS-like CoVs. Formula C12H13N5O4, MW 291.26. Research-grade with COA.
Molecular Information
CAS: 1191237-69-0
Formula: C12H13N5O4
MW: 291.26 g/mol
Class: Adenosine nucleoside analog
Core: 1'-cyano pyrrolo[2,1-f][1,2,4]triazine ribonucleoside
Target: Viral RNA-dependent RNA polymerase (RdRp)
Activity: Chain-terminating antiviral
MP: Not firmly reported
Appearance: White to off-white powder
Synonyms: GS441524 / Remdesivir nucleoside
Storage: -20°C, protect from light
Product Technical Specifications
Complete physicochemical properties and QC parameters for GS-441524 (CAS 1191237-69-0)
📋 Physicochemical Properties
- Product NameGS-441524
- IUPAC Name(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile
- CAS Number1191237-69-0
- SynonymsGS-441524; GS441524; Remdesivir nucleoside
- Molecular FormulaC12H13N5O4
- Molecular Weight291.26 g/mol
- SourceSynthetic nucleoside analog
- AppearanceWhite to off-white powder
- Water SolubilityLow to moderate
- Organic SolubilityDMSO; aqueous buffer (pH-dependent)
- Compound ClassAdenosine nucleoside analog / antiviral
- HS Code2934.99
🔬 Quality Control & Handling
- Purity (HPLC)≥98%
- FormCrystalline powder
- Primary TargetViral RNA-dependent RNA polymerase (RdRp)
- Assay ReadoutViral replication / plaque reduction
- SelectivityActive vs coronavirus polymerases
- Storage Condition-20°C, sealed, protect from light
- Solution StabilityDMSO stock stable weeks at -20°C
- ShippingCold chain recommended
- QC DocumentationCOA / HPLC / NMR / MS / MSDS
- Pack Sizes100mg / 500mg / 1g / 5g / 10g
- Stock StatusIn Stock
- Use StatementResearch / veterinary investigational; not for human use
Key Molecular Targets & Pathway Nodes
GS-441524 engages the molecular machinery and pathway nodes that define its research utility.
How GS-441524 Works: Terminating Viral RNA Synthesis
GS-441524 is phosphorylated intracellularly and caps viral RNA chains via the viral polymerase
Cellular Phosphorylation to the Active Triphosphate
After uptake, GS-441524 (the nucleoside core of remdesivir) is converted by host kinases to its 5'-triphosphate, the species that engages the viral replication machinery.
Incorporation by the Viral RdRp
The triphosphate is recognized and incorporated by the viral RNA-dependent RNA polymerase (RdRp) in place of the natural nucleotide during nascent viral RNA synthesis.
Chain Termination & Replication Arrest
Because the analog lacks the 3'-OH needed for further elongation, incorporation terminates the RNA chain, halting coronavirus genome replication and spread — the basis of its efficacy against FIPV and related CoVs.
⚖️ GS-441524 vs Comparators
- GS-441524 (this product)Active nucleoside; RdRp chain terminator
- Remdesivir (GS-5734)Phosphoramidate prodrug of GS-441524
- MolnupiravirRdRp mutagen (different mechanism)
- Nucleotide FocusIntracellular triphosphate is the effector
- Research NicheFIP / coronavirus antiviral models
♻️ Downstream Biological Consequences
- Viral RNAChain termination; no elongation
- ReplicationPlaque / titer reduction
- CellsHost kinase activation to triphosphate
- CoronavirusFIPV & SARS-like CoV suppression
- AssaysPlaque reduction; qRT-PCR
- TherapyCombination antiviral strategies
Research Applications & Models
GS-441524 is the reference nucleoside for coronavirus and FIP antiviral research.
FIP (Feline Infectious Peritonitis)
The benchmark nucleoside studied for FIPV antiviral therapy in veterinary research models.
FIP / FIPVCoronavirus Antiviral Studies
Probes RdRp inhibition across SARS-like and endemic coronaviruses.
CoronavirusNucleoside Analog Profiling
Benchmark for chain-terminating antiviral nucleosides and SAR.
NucleosideRdRp & Replication Assays
Plaque reduction, qRT-PCR and polymerase incorporation studies.
RdRpVeterinary / Companion-Animal Models
Investigational antiviral work in feline and small-animal systems.
VeterinaryCombination Screening
Paired with protease inhibitors (e.g., GC376) for synergy.
ComboKey Literature & Landmark Publications
Landmark work on remdesivir-class nucleosides and FIP antiviral therapy.
Available Sizes & Ordering
Research-grade GS-441524 (CAS 1191237-69-0) with full QC documentation; standard packs and bulk custom quantities supported.
| Tier | Pack Size | Stock Status | Suitable For | Lead Time |
|---|---|---|---|---|
| Standard | 100mg | In Stock | Antiviral / cell assays | Same/next-day ship |
| Medium | 500mg | In Stock | FIP / coronavirus models | Same/next-day ship |
| Large | 1g | In Stock | In vivo antiviral studies | Same/next-day ship |
| Bulk | 5g | In Stock | Formulation & screening | Quote to confirm |
| Industrial | 10g+ | Made to order | Process development | Batch delivery |
💡 Reference sizes shown above; for exact pricing and availability please contact us for a quote. Bulk orders qualify for tiered discounts.
Frequently Asked Questions (FAQ)
What is GS-441524 and how is it related to remdesivir?
Why is GS-441524 studied for FIP?
Is GS-441524 the same as remdesivir?
What readouts confirm antiviral activity?
How soluble is GS-441524 and how should it be prepared?
Is QC documentation provided?
Need GS-441524 for Your Research?
Research-grade GS-441524 (CAS 1191237-69-0) — purity ≥98% HPLC, COA included
Viral RdRp Inhibitor — request a quote today




